Cardiol Therapeutics Inc.
CRDL · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $132 | $72 | $43 | $101 |
| - Cash | $31 | $35 | $44 | $84 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $101 | $37 | -$1 | $17 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | -100% | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | -179.9% |
| EBITDA | -$40 | -$21 | -$23 | -$25 |
| % Margin | – | – | – | -39,891% |
| Net Income | -$37 | -$21 | -$23 | -$25 |
| % Margin | – | – | – | -40,170.9% |
| EPS Diluted | -0.51 | -0.44 | -0.49 | -0.73 |
| % Growth | -15.9% | 10.2% | 32.9% | – |
| Operating Cash Flow | -$25 | -$25 | -$27 | -$24 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$25 | -$25 | -$27 | -$24 |